| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-04-0323 |
| P698 | PubMed publication ID | 15150096 |
| P50 | author | Woodring E. Wright | Q59693488 |
| Jerry W Shay | Q89873929 | ||
| P2093 | author name string | Ying Zou | |
| Oliver E Bechter | |||
| William Walker | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colon cancer | Q18555025 |
| DNA mismatch repair | Q2984243 | ||
| P304 | page(s) | 3444-3451 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition | |
| P478 | volume | 64 |
| Q80568732 | A SUMO ligase for ALT |
| Q40382157 | A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. |
| Q89509813 | ALT: A Multi-Faceted Phenomenon |
| Q92375621 | ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity |
| Q43146455 | Altered states of telomere deprotection and the two-stage mechanism of replicative aging |
| Q37515442 | Alternative lengthening of human telomeres is a conservative DNA replication process with features of break-induced replication |
| Q33558285 | Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands |
| Q34107386 | Alternative lengthening of telomeres: models, mechanisms and implications |
| Q38083475 | Alternative lengthening of telomeres: remodeling the telomere architecture |
| Q33900715 | An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres |
| Q37420553 | Analysis of alternative lengthening of telomere markers in BRCA1 defective cells |
| Q61195888 | Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome |
| Q37764530 | Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers. |
| Q28070584 | Balancing self-renewal against genome preservation in stem cells: How do they manage to have the cake and eat it too? |
| Q64099070 | Binding of BRACO19 to a Telomeric G-Quadruplex DNA Probed by All-Atom Molecular Dynamics Simulations with Explicit Solvent |
| Q54504193 | Cancer. Cancer and telomeres--an ALTernative to telomerase. |
| Q27026386 | Causal link between microsatellite instability and hMRE11 dysfunction in human cancers |
| Q28474871 | Cell proliferation in the presence of telomerase |
| Q37920517 | Chromosomal aberrations involving telomeres and interstitial telomeric sequences |
| Q37163052 | Control of telomere length by a trimming mechanism that involves generation of t-circles |
| Q38595733 | DNA excision repair at telomeres |
| Q57239953 | DNA methyltransferases control telomere length and telomere recombination in mammalian cells |
| Q24647002 | DNA mismatch repair: molecular mechanism, cancer, and ageing |
| Q35946397 | Deficient mismatch repair improves organismal fitness and survival of mice with dysfunctional telomeres |
| Q39898215 | Detection of circular telomeric DNA without 2D gel electrophoresis |
| Q42561321 | Determining if telomeres matter in colon cancer initiation or progression |
| Q36343157 | Differential requirements for DNA repair proteins in immortalized cell lines using alternative lengthening of telomere mechanisms |
| Q64983487 | Dynamics of Telomere Rejuvenation during Chemical Induction to Pluripotent Stem Cells. |
| Q33275302 | Elevated rates of sister chromatid exchange at chromosome ends |
| Q34116956 | Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway |
| Q38662646 | Emerging roles of ATRX in cancer |
| Q39944681 | Epigenetic regulation of telomeres in human cancer. |
| Q90327923 | Expanding the chemotherapeutic potential of an established nucleoside analog with selective targeting of telomerase |
| Q36827578 | Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells |
| Q38593886 | G-Quadruplex binding enantiomers show chiral selective interactions with human telomere. |
| Q37675160 | Genistein suppresses the proliferation of telomerase-negative cells |
| Q33554104 | Human MLH1 suppresses the insertion of telomeric sequences at intra-chromosomal sites in telomerase-expressing cells |
| Q34943419 | Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine |
| Q39140555 | Inter-telomeric recombination is present in telomerase-positive human cells |
| Q40302541 | Involvement of topoisomerase III in telomere-telomere recombination |
| Q54334207 | Keeping those telomeres short! an innovative intratumoral long-term drug delivery system. |
| Q56969633 | Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination |
| Q34469050 | Long telomeres produced by telomerase-resistant recombination are established from a single source and are subject to extreme sequence scrambling |
| Q36210968 | Maintenance of very long telomeres by recombination in the Kluyveromyces lactis stn1-M1 mutant involves extreme telomeric turnover, telomeric circles, and concerted telomeric amplification |
| Q38168515 | Modern aspects of the structural and functional organization of the DNA mismatch repair system |
| Q81580735 | Msh2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect |
| Q49650521 | Non-random length distribution of individual telomeres in immunodeficiency, centromeric instability and facial anomalies syndrome, type I. |
| Q94586161 | Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma |
| Q38963433 | NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. |
| Q38008909 | PML body meets telomere: the beginning of an ALTernate ending? |
| Q34361226 | Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs |
| Q33794933 | Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers |
| Q36119246 | Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination |
| Q37220140 | Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX. |
| Q37110604 | TRF1 controls telomere length and mitotic fidelity in epithelial homeostasis. |
| Q37750789 | Targeting telomerase in hematologic malignancy |
| Q35589168 | Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis |
| Q36177993 | Telomerase activity in colorectal cancer, prognostic factor and implications in the microsatellite instability pathway |
| Q58276136 | Telomerase as Biomarker in Colorectal Cancer |
| Q39713310 | Telomerase inhibition alters telomere maintenance mechanisms in laryngeal squamous carcinoma cells |
| Q36638624 | Telomerase inhibition in cancer therapeutics: molecular-based approaches |
| Q47916801 | Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma. |
| Q26786613 | Telomerase reverse transcriptase moonlights: Therapeutic targets beyond telomerase |
| Q49803981 | Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT). |
| Q37906713 | Telomere dynamics: the influence of folate and DNA methylation |
| Q28512777 | Telomere lengthening early in development |
| Q37046752 | Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells. |
| Q29615353 | Telomeres and human disease: ageing, cancer and beyond |
| Q38195033 | Telomeres, telomerase and colorectal cancer |
| Q33982700 | Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops |
| Q34489869 | Telomeric recombination induced by dysfunctional telomeres |
| Q39208134 | The many facets of homologous recombination at telomeres |
| Q26829119 | The role of RecQ helicases in non-homologous end-joining |
| Q93117015 | The role of telomeres and telomerase in cirrhosis and liver cancer |
| Q36629410 | The roles of telomerase in the generation of polyploidy during neoplastic cell growth |
| Q42340879 | The telomere protein tankyrase 1 regulates DNA damage responses at telomeres |
| Q90744618 | Therapeutic Targets in Telomerase and Telomere Biology of Cancers |
| Q38937312 | Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers. |
| Q26865127 | Toward a molecular classification of colorectal cancer: the role of telomere length |
| Q34081803 | Twisted epithelial-to-mesenchymal transition promotes progression of surviving bladder cancer T24 cells with hTERT-dysfunction |
| Q39915528 | Unusual telomeric DNAs in human telomerase-negative immortalized cells |
| Q36455904 | Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells. |
| Q28542061 | WRN loss induces switching of telomerase-independent mechanisms of telomere elongation |
Search more.